MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation. [electronic resource]

By: Contributor(s): Producer: 20160505Description: 279-87 p. digitalISSN:
  • 1759-7706
Online resources: In: Thoracic cancer vol. 7
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.